Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03263637
Title Study to Assess Safety, Tolerability, Pharmacokinetics and Antitumor Activity of AZD4573 in Relapsed/Refractory Haematological Malignancies
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications

acute myeloid leukemia

chronic lymphocytic leukemia

acute lymphoblastic leukemia

CLL/SLL

multiple myeloma

hematologic cancer

Richter's syndrome

myelodysplastic syndrome

non-Hodgkin lymphoma

chronic myelomonocytic leukemia

Therapies

AZD4573

Age Groups: senior | adult
Covered Countries


No variant requirements are available.